This article has Open Peer Review reports available.
Antimalarial activity of 80 % methanolic extract of Brassica nigra (L.) Koch. (Brassicaceae) seeds against Plasmodium berghei infection in mice
© Muluye et al. 2015
Received: 13 July 2015
Accepted: 4 October 2015
Published: 15 October 2015
Resistances to currently available drugs and insecticides, significant drug toxicities and costs and lack of vaccines currently complicated the treatment of malaria. A continued search for safe, effective and affordable plant-based antimalarial agents thus becomes crucial and vital in the face of these difficulties. The aim of the study was to evaluate the antimalarial activity of 80 % methanolic extract of the seeds of Brassica nigra against Plasmodium berghei infection in mice.
Chloroquine sensitive Plasmodium berghei (ANKA strain) was used to test the antimalarial activity of the extract. In suppressive and prophylactic models, Swiss albino male mice were randomly grouped into five groups of five mice each. Group I mice were treated with the vehicle, group II, III and IV were treated with 100, 200, and 400 mg/kg of the extract, respectively and the last group (V) mice were treated with chloroquine (10 mg/kg). The level of parasitemia, survival time and variation in weight of mice were used to determine the antimalarial activity of the extract.
Chemosuppressive activities produced by the extract of the seeds of Brassica nigra were 21.88, 50.00 (P < 0.01) and 53.13 % (P < 0.01), while the chemoprophylactic activities were 17.42, 21.21 and 53.79 % (P < 0.05) at 100, 200 and 400 mg/kg of the extract, respectively as compared to the negative control. Mice treated with 200 and 400 mg/kg extract were significantly (P < 0.05) lived longer and gained weight as compared to negative control in 4-day suppressive test.
From this study, it can be concluded that the seed extract of Brassica nigra showed good chemosuppressive and moderate chemoprophylactic activities and the plant may contain biologically active principles which are relevant in the treatment and prophylaxis of malaria, thus supporting further studies of the plant for its active components.
Malaria is a serious hazard to humanity and the major cause of mortality and morbidity in the malaria-endemic countries. Even though the distribution of the disease is substantially varied, sub-Saharan Africa, Asia and Central and Latin America are the most affected regions. About 50 % of populations in the world live in malaria risk areas. In 2013, it was estimated that 198 million cases of malaria and 584,000 malarial deaths have been occurred in the world. The burden of the disease is heaviest in Africa, where 82 and 90 % of all global cases and deaths were occurred, respectively .
Resistances of mosquitoes to insecticides and parasites to antimalarial drugs especially to the current most effective and newest artemisinin derivatives have led to an increase in severe malaria and complicate the eradication of the disease as well as the resurgence of malaria . While there is much need and there is currently no alternative to the precious artemisinin derivatives, the antimalarial drug development pipeline remains sadly thin with little chemical diversity . Preventive and treatment strategies of malaria are not only continuously hampered by the issues of resistance but also considerable costs and logistical problems especially in poor malarious countries as well as a challenge of having effective vaccines create a great and urgent concern for the treatment of the disease .
Additionally, many antimalarial drugs in use today have high toxicity and low therapeutic margin of indices that exposes patients’ additional harm and health expenditure . The efficacy, safety and quality of most medicinal plant products in traditional medicine are not validated and standardized. Medicinal plants used in traditional medicine should, therefore, be studied for their safety and efficacy and their quality as well to safe guard the health of customers .
In the face of current resistance problems, medicinal plants are a potential source of new, effective and affordable antimalarial agents. However, most of these plants, represent a virtually unlimited reservoir of molecules, are not explored chemically and can constitute lead molecules for development of new antimalarial drugs. Therefore, antimalarial drug discovery from such plants is currently more targeted because histories proved that plants are richest sources of antimalarial phytochemicals [7, 8].
Quinine and artemisinin, two main classes of antimalarials, currently in use have been provided by Cinchona species and Artemisia annua traditionally used for malaria for a long period of times, respectively. Therefore, medicinal plants have made and continue to make a great contribution to antimalarial chemotherapy as they contain molecules with a great variety of structures and biological activities [9, 10].
The genus Brassica is reported to comprise over 150 species, of which five including Brassica nigra are found in Ethiopian flora. Brassica nigra (local Ethiopian Amharic name: Senafitch) is an annual, erect, aromatic, up to 100 cm tall with freely and widely branching, and glabrate weedy herb . Brassica nigra is used throughout the world for various aspects such as food, vegetable, medicinal and industrial products. The medicinal effect is mainly confined to its seeds. The seeds have been used as tonic, digestive, emetic, appetite stimulant, laxatives, antiseptics and for carcinoma and tumors , liver and spleen indurations, abscesses, colds, headaches, rheumatism, edema, neuralgia, alopecia, epilepsy, snakebite, toothache, hiccup, pneumonia  and malaria [14, 15]. Its seeds are powdered and a paste have been made with water and then eaten with and without “Injera” (a flat Ethiopian bread resembling a large pancake) for the prevention and treatment of malaria, respectively, in Ethiopia .
The seed extract of Brassica nigra showed potent antiepileptic activity  which might be important for the management of cerebral malaria which is associated with protracted and/or febrile convulsions. The plant is also endowed with various pharmacologically active phytochemicals, such as alkaloids, flavonoids, tannins, terpenoids, and others [17, 18], with reported antiplasmodial activity  and hence this also justified the current study.
Considering all the above since there is no previous report, laboratory-based evidence for its antimalarial effectiveness is found essential. This study is, therefore, designed to evaluate the antimalarial activity of the 80 % methanolic extract of the seeds of Brassica nigra against Plasmodium berghei infection in mice.
Collection and preparation of the plant materials
The fresh seeds of Brassica nigra were collected from the farmers’ farmland in November 2014, around Gondar town, 728 km from Addis Ababa, Northwest Ethiopia. The plant was identified and authenticated and a voucher specimen (with a voucher number of AB05) was deposited at National Herbarium, Addis Ababa University, Ethiopia. The seeds of Brassica nigra were cleaned and air-dried in the shade at room temperature. The dried seeds were coarsely powdered using mortar and pestle. Then the powdered plant materials were stored in a plastic container and they were kept at room temperature until extraction.
Extraction of the plant materials
The powdered samples of seeds of B. nigra (325 g) were weighed by sensitive balance. They were extracted by maceration with 80 % methanol (1:10 ratio of powdered plant material (in gram) and solvent (in millitre), respectively) for three consecutive days with occasional stirring. After 72 h, the mixture was filtered with Whatman filter paper no 1 (Whatman, England). The residue was re-macerated twice for the same duration of hours and then the mixture were filtered . The combined filtrates were dried by oven (250 V, France) set below 40 °C. The weight of the dried extract was measured to determine the percentage yield. Finally, the dried extract was then transferred into a vial and it was kept in a refrigerator until further use.
Fifty Swiss albino male mice, weighing 25 to 32 g and 6 to 8 weeks old inbred at the Animal House of the Department of Pharmacology, University of Gondar were used. They were housed in plastic cages with softwood shavings and chips as beddings. They were exposed to a 12:12 dark-to-light cycle. They had free access to pellet diet and clean drinking water. All mice were acclimatized to the working environment one week before the beginning of the experiment .
Chloroquine sensitive Plasmodium berghei (ANKA strain) was used for induction of malaria in experimental mice. Mice previously infected with P. berghei were used as donor. The donor P. berghei infected mice were obtained from Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Ethiopia. The parasites were subsequently maintained in the laboratory by serial passage of blood from donor infected mice to naive one via intra-peritoneal (IP) route on weekly basis .
Drugs and reagents
Chloroquine (Addis Pharmaceuticals Factory, Ethiopia), methanol (Okhla Industrial, India), Giemsa (Sciencelab, USA), trisodium citrate (Deluxe Scientific surgico, India), ketamine (Rotexmedica, Germany) and normal saline (Addis Pharmaceuticals Factory, Ethiopia) were used. All reagents were analytically graded and procured from certified suppliers.
Study design and sampling method
Experimental study design was used. Simple random sampling technique was employed for grouping of experimental animals and assignments of treatments.
The parasitemia of the previously P. berghei infected donor mouse were determined. After anaesthetizing with ketamine, the blood from these mice was collected via cardiac puncture with a rising parasitaemia of 30 to 35 % into a test tube having 0.5 % trisodium citrate which was added as anticoagulant. The blood was then diluted with normal saline (0.9 %) to give 2 × 107 IRBCs in an injection volume of 0.2 ml. The amount of normal saline used in the dilution was determined by the level of parasitaemia (%) of the infected donor mice. If 0.5 ml of blood was removed then dilution was done with (X-0.5) ml of saline, where X was the % parasitaemia. Each mouse was then infected by injecting 0.2 ml of this diluted blood via IP which contained 2 × 107 IRBCs, which produces a steadily rising infection in mice [21, 22].
Grouping and dosing of animals
For each model (suppressive and prophylactic), twenty five mice were grouped into five groups of five mice each. Group I mice were treated with the vehicle (distilled water, 10 ml/kg, served as negative control), group II, III and IV mice were treated with 100, 200, and 400 mg/kg of crude extract, respectively and the last group (V) mice were treated with the standard drug (chloroquine, 10 mg/kg, served as positive control).
The safety data of the plant was obtained from Praveen et al.  as the crude methanolic extract of the seeds of B. nigra was safe at 2000 mg/kg in mice and this was a basis for the selection of the three dose levels (100, 200 and 400 mg/kg) of the extract for the current antimalarial activity evaluation. As people traditionally use the plant material for treatment and prevention of malaria orally , each treatment was administered through oral route using oral gavage to ensure safe ingestion of the preparations.
Four-day suppressive antimalarial test
Plasmodium berghei four-day suppressive test, the most widely used preliminary test, in which the efficacy of four daily doses of new compounds is measured by comparison of blood parasitaemia and survival times of treated and untreated mice. The test provides a preclinical indication of potential bioactivity of the extract [21, 23]. The test was done by a method described by Fidock et al. . After standard parasite inoculation (2 × 107 P. berghei IRBCs, 0.2 ml), 25 mice were randomly divided into five groups with five mice each as above mentioned in grouping of animals. Treatment was started three hours after infection and then continued for three consecutive days (i.e., from D0 to D3). On the 5th day (D4), thin blood films were made from the tail of each mouse on a microscopic slide (Citoplus, China).
Prophylactic antimalarial test
Compounds identified as being active in four-day suppressive assays can subsequently be further examined through the use of several secondary tests in mice from which prophylactic test are one of them. Evaluation of prophylactic potential of the extract was done according to Fidock et al. . Twenty five mice were randomly grouped into five groups as mentioned above accordingly and then treated for four consecutive days (D0 to D3). On the fifth day (D4), a standard inoculum (2 × 107 P. berghei IRBCs, 0.2 ml) was administered by IP to each mouse. After 72 h of infection (D7), thin blood smears were prepared from tail of each mouse on a microscopic slide.
Peripheral blood smear preparation
For both models (suppressive and prophylactic), thin smears of blood were made from the tail of each mouse on the fifth day (D4) and eighth day (D7), respectively. The smears were applied on microscopic slides and the bloods were drawn evenly across a second slide to make thin blood films and allowed to dry at room temperature. Then they were fixed with 100 % methanol and stained with 10 % Giemsa stain at pH 7.2 for 15 min.
Determination of mean survival time
Body weight determination
Body weight loss is one feature of rodent malaria infections. Body weight change is another parameter used to assess the effectiveness of plant extracts . The body weight of each mouse in all groups was taken before infection (D0) and treatment (D1) and after treatment (D4) and infection (D7), in suppressive and prophylactic tests, respectively. The weight of each mouse was measured using sensitive electrical balance (ADP 720 L, Adam Equipment). Then, % body weight change of extract treated groups was compared with the control groups.
The data of the study were expressed as mean ± SEM (standard error of mean) for each group of experiments. Data on the levels of parasitemia, variations in body weight and survival times were analyzed using windows SPSS version 16.0. The differences between means of measured parameters were compared using one-way ANOVA followed by Turkey’s HSD multiple comparison test and paired sample t-test (two-tailed). The P values < 0.05 were regarded as statistically significant.
Data quality control
The quality of data was assured by using randomization during grouping of experimental animals and assignments of treatments. Codes were used for all microscopic slides. Parasitized RBCs were counted blindly by a laboratory technician.
During experimental procedures, experimental animals were handled and cared according to the internationally accepted laboratory animals’ use, care and welfare guideline . Ethical clearance was requested to and obtained from animal ethics committee of Department of Pharmacology, School of Pharmacy, University of Gondar.
Percentage yield of the plant material
The percentage yield of the dry matter of the 80 % methanolic crude extract of the seeds of Brassica nigra was 9.85 % w/w. Its actual yield was 32 g. It was red in its colour. Hygroscopic powder was formed after drying.
Four-day suppressive antimalarial activity of the extract
Four-day chemosuppressive activity of methanolic crude extract of the seeds of Brassica nigra against Plasmodium berghei infection in mice
25.60 ± 2.40
Brassica nigra seed extract
20.00 ± 2.53
12.80 ± 0.80
12.00 ± 2.83
1.40 ± 0.75
Even though there were differences in parasitemia suppression among extract treated groups, they were statistically non-significant.
Chemoprophylactic antimalarial activity of the extract
Chemoprophylactic activity of methanolic crude extract of the seeds of Brassica nigra against Plasmodium berghei infection in mice
26.40 ± 5.80
Brassica nigra seed extract
21.80 ± 2.65
20.80 ± 3.01
12.20 ± 1.36
1.00 ± 0.45
There were no statistically significant chemoprophylactic differences among extract treated groups as that of four-day suppressive test.
Effect of extract on survival times of mice
Effect of crude methanolic extract of the seeds of B. nigra on the mean survival times of P. berghei infected mice in both suppressive and prophylactic tests
Mean Survival Times (Days)
7.20 ± 0.37
Brassica nigra seed extract
7.60 ± 0.25b2
9.00 ± 0.45a1,b2
9.00 ± 0.71a1,b2
15.00 ± 0.00a2
6.80 ± 0.20
Brassica nigra seed extract
7.00 ± 0.32b2
7.60 ± 0.25b2
7.80 ± 0.37b2
14.60 ± 0.40a2
Effect of extract on body weights of mice
Effect of crude methanolic extract of the seeds of B. nigra on the body weights of P. berghei infected mice in suppressive test
Body Weight (gm)
Wt Change (%)
29.64 ± 0.34
29.30 ± 0.32
Brassica nigra seed extract
30.38 ± 1.89
30.48 ± 2.05
26.68 ± 1.57
26.92 ± 1.57
29.26 ± 1.41
29.62 ± 1.42
28.18 ± 1.64
28.58 ± 1.65
Effect of crude methanolic extract of the seeds of B. nigra on the body weights of P. berghei infected mice in prophylactic test
Body Weight (gm)
Wt Change (%)
24.94 ± 1.99
24.48 ± 2.00
Brassica nigra seed extract
26.80 ± 0.99
27.00 ± 0.94
25.84 ± 2.42
26.06 ± 2.50
28.10 ± 1.56
28.42 ± 1.68
26.86 ± 1.13
27.34 ± 1.17
The antimalarial activity of the crude methanolic extract of the seeds of Brassica nigra, used in traditional medicine in Ethiopia and elsewhere, against Plasmodium berghei infection in mice in both four-day suppressive and prophylactic test models are reported.
The percentage suppression of parasitaemia of the extract treated groups changed significantly from those in the negative control group showing that the extract has antimalarial activity supporting the folk use of the plant as antimalarial herb. A compound is considered as active when percent suppression in parasitemia is 30 % or more [26, 27], which supports the findings of the current study.
The mice treated with 200 and 400 mg/kg of extract showed significant 50.00 and 53.13 % chemosuppressions, respectively, as compared to negative control. The chemosuppressive effects of the extract of the seeds of Brassica nigra in the current study were in agreement with other reports on medicinal plants used for malaria such as Echinops kebericho ; Agelanthus dodeneifolius ; Sida rhombifolia  and Phytolacca dodecandra  which showed significant 29.46 % and 57.29; 48.02 and 50.50; 50.10 and 52.30; and 50.93 and 55.24 % chemosuppressions, respectively, with similar doses.
According to Deharo et al. , in vivo antimalarial activity of plant extracts can be categorized as: moderate, good and very good if the extract showed 50 % or more chemosuppression at 500, 250 and 100 mg/kg/day extract dose, respectively. Hence, the current finding revealed that hydroalcoholic seed extract of B. nigra has good 4-day suppressive antimalarial activity.
The methanolic seed extract of B. nigra also showed significant chemoprophylactic activity against residual infection at 400 mg/kg as 53.79 % chemosuppression. The current finding was in agreement with other reports on medicinal plants used for malaria such as Languas galangal  and Agelanthus dodeneifolius  which showed significant 52.00 and 56.00 % chemosuppression, respectively. According to Deharo et al.  in vivo antimalarial activity classification, the methanolic crude extract of the seeds of Brassica nigra showed moderate chemoprophylactic antimalarial activity.
In both models (suppressive and prophylactic), chloroquine, the current antimalarial drug, was used as a reference drug [21, 25] and it showed parasitemia suppression near to undetectable levels of 94.53 and 96.21 %, respectively. It leads to decreased parasitemia and resultant recovery of severe malaria by reducing parasite nutrient intake as well as by interfering with parasite metabolic machinery involved with iron . The chemosuppression showed by chloroquine in the current study was in agreement with other studies on medicinal plants used for malaria such as Artemisia annua , Annona senegalensis  and Adhathoda schimperiana  which showed 90.48, 96.20 and 97.80 %, respectively.
The pharmacological (i.e., the antiplasmodial) activities of plants are due to the presence of bioactive secondary metabolites in the crude plant material . Basically, different secondary metabolites, such as alkaloids, glycosides, phenols, terpenoids and sterols , flavonoids and tannins , have been reported from the seed extract of Brassica nigra. These metabolites have antiplasmodial activities [9, 10, 37, 38]. However, the active compound(s) responsible for this observed antiplasmodial activity need to be identified.
Therefore, the antiplasmodial activity observed in this plant could have resulted from single or in combined action of the above metabolites . The possible mechanisms of antiplasmodial activity might be through anti-oxidation and free radical scavenging , immunomodulatory , intercalation in DNA, inhibition of protein synthesis, interference with the invasion of new RBCs by parasites, or by any other unknown mechanisms [29, 39].
Mean survival time is another parameter evaluates the antimalarial activity of plant extracts. Accordingly, a plant material that can prolong the survival time of infected experimental animals compared to the negative controls are considered as active agents against malaria . An extract that results in survival time greater than that of infected non-treated mice was considered as active . In this study the mice treated with 200 and 400 mg of extract had significantly lived longer than negative control in four-day suppressive test. This might be due to the antiplasmodial activity of the extract. However, the survival times of mice treated with the extract were shorter as compared to positive control; this might be the fast elimination phase of the extract. The current findings were in agreement with studies done on medicinal plants used for malaria such as Dodonaea angustifolia  and Nigella sativa .
Body weight loss is one manifestation of Plasmodium berghei-infected mice. This is due to the depressant action on the appetite of the mice and the consequences of disturbed metabolic function and hypoglycemic effect of the parasite . Body weight change of mice is also another parameter that evaluates the antimalarial activity of plant extracts . Mice treated with 200 and 400 mg/kg of extract showed a significant increased in body weight gain as compared to negative control, hence, this might tell us the antiplasmodial activity of the extract.
The plant possesses other pharmacologic benefits which might in part lead to increased weight gain including appetite stimulant activity  and it is nutritionally endowed with vitamin Bs such as vitamin B1, thiamine which maintains appetite and growth; vitamin B2, riboflavin which prevents skin lesions and weight loss; and vitamin B3, niacin which maintains the normal function of the nervous system and the gastrointestinal tract . However, the weight gains of extract treated mice were insignificant as compared to the negative control in prophylactic test. This might be the rapid hepatic clearance of the active component of the plant, which was given before infection at which the basal metabolic rate of the mice is active, involved in weight gain. This finding was in agreement with other study on medicinal plant, Faidherbia albida , used for malaria.
From this study, it can be concluded that the seeds of Brassica nigra showed good chemosuppressive and moderate chemoprophylactic antimalarial activities against Plasmodium berghei infection in mice. Accordingly, with the essence of further studies this plant could serve as the potential source of new and novel antimalarial leads and/or drugs for the treatment and prevention of malaria.
We would like to thank Wollega university and University of Gondar for their financial and materials support, respectively. Lastly, our gratitude will goes to Mr. Zemene Demelash for his assistance in the laboratory procedures.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- World Health Organization (WHO). World Malaria Report. Switzerland: Geneva.2014. [pdf] Available from: http://www.who.int/malaria/publications/world_malaria_report_2014/wmr-2014-no-profiles.pdf [Accessed on 14th December 2014].
- Silva JRA, Ramos AS, Machado M, deMoura DF, Neto Z, Canto-Cavalheir MM, et al. A Review of Antimalarial Plants Used in Traditional Medicine in Communities in Portuguese-Speaking Countries: Brazil, Mozambique, Cape Verde, Guinea-Bissau, São Tomé and Príncipe and Angola. Mem Inst Oswaldo Cruz. 2011;106:142–58.View ArticlePubMedGoogle Scholar
- Grimberg BT, Mehlotra RK. Expanding the Antimalarial Drug Arsenal-Now, But How? Pharmaceuticals. 2011;4:681–712.PubMed CentralView ArticlePubMedGoogle Scholar
- Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to Malaria: More Questions than Answers. Nat Immunol. 2008;9:725–32.View ArticlePubMedGoogle Scholar
- Sullivan JDJ, Kaludov N, Martinov MN. Discovery of Potent, Novel, Non-Toxic Antimalarial Compounds via Quantum Modelling, Virtual Screening and In Vitro Experimental Validation. Malar J. 2011;10:274–82.PubMed CentralView ArticlePubMedGoogle Scholar
- Folashade KO, Omoregie EH, Ochogu AP. Standardization of Herbal Medicines - A Review. Int J Biodvers Conserv. 2012;4:101–12.Google Scholar
- Pandey A, Tripathi S. Concept of Standardization, Extraction and Pre-Phytochemical Screening Strategies for Herbal Drug. J Pharmacogn Phytochem. 2014;2:115–9.Google Scholar
- Onguéné PA, Ntie-Kang F, Lifongo LL, Ndom JC, Sippl W, Mbaze LM. The Potential of Antimalarial Compounds Derived from African Medicinal Plants. Part I: A Pharmacological Evaluation of Alkaloids and Terpenoids. Malar J. 2013;12:449–74.View ArticleGoogle Scholar
- Willcox ML and Gilbert B. Traditional Medicinal Plants for the Treatment and Prevention of Human Parasitic Diseases. In: Elisabetsky E, Etkin NL (eds.) Ethnopharmacology. 2005. [pdf] Available from: http://www.eolss.net/Eolss-sampleAllChapter.aspx [Accessed on 14th December 2014].
- Bero J, Frederich M, Quetin-Leclercq J. Antimalarial Compounds Isolated from Plants Used in Traditional Medicine. J Pharm Pharmacol. 2009;61:1401–33.View ArticlePubMedGoogle Scholar
- Jonsell B. Brassicaceae. In: Hedberg I, Edwards S, Tadesse M, Demissew S, editors. Flora of Ethiopia and Eritrea. Vol. 2, part 1. Ethiopia: National Herbarium; 2000. p. 121–54.Google Scholar
- Amri E. The Role of Selected Plant Families with Dietary Ethnomedicinal Species Used as Anticancer. J Med Plants Stud. 2014;2:28–39.Google Scholar
- Lim TK. Edible Medicinal Plants and Non-medicinal Plants. India: Springer Science and Business; 2013. [Online] Available from: http://www.springer.com/lifesciences/plantsciences/book/978-94-007-5652-6 [Accessed on12th December 2014].
- Endale A. Ethnobotanical Study of Antimalarial Plants in Dembia District, North Gondar, Amhara Region, Northwest Ethiopia. Biochem Pharmacol. 2013;2:180.Google Scholar
- Ghafari S, Esmaeili S, Naghibi F, Mosaddegh M. Plants Used to Treat Malaria Like Fever in Iranian Traditional Medicine. Intl J Trad Herb Med. 2013;1:168–76.Google Scholar
- Praveen KU, Naga PK, Murali KB, Swarnalatha M. Evaluation of Antiepileptic Activity of Methanolic Extract of Brassica nigra Seeds in Mice. IJPI. 2013;3:73–84.Google Scholar
- Tomar RS, Shrivastava V. Efficacy Evaluation of Ethanolic Extract of Brassica nigra as Potential Antimicrobial Agent against Selected Microorganisms. IJPHC. 2014;3:117–23.Google Scholar
- Shafaghat A. Phytochemical Investigation of Quranic Fruits and Plants. J Med Plants Res. 2010;9:61–6.Google Scholar
- Cannell RJP. Natural Products Isolation. In: Sarker SD, Latif Z, Gray AI, editors. Methods in Biotechnology. 2nd ed. New Jersey: Humana Press Inc; 2006.Google Scholar
- Institute for Laboratory Animal Research (ILAR). Guide for the Care and Use of Laboratory Animals. 8th ed. Washington DC: National Academic Press; 2011.Google Scholar
- Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S. Antimalarial Drug Discovery: Efficacy Models for Compound Screening. Nat Rev Drug Discov. 2004;3:509–20.View ArticlePubMedGoogle Scholar
- Basir R, Fazalul Rahiman SS, Hasballah K, Chong WC, Talib H, Yam MF, et al. Plasmodium berghei ANKA Infection in ICR Mice as a Model of Cerebral Malaria. Iranian J Parasitol. 2012;7:62–74.Google Scholar
- Dori GU, Nzangue RT and Yerbanga SR. Traditional Medicine Research for the Discovery of Novel Antimalarial Compounds. 2008. [pdf] Available from: http://www.researchgate.et/publication/232710028 [Accessed on 12th January 2015].
- Kalra BS, Chawla S, Gupta P, Valecha N. Screening of Antimalarial Drugs: An Overview. Indian J Pharmacol. 2006;38:5–12.View ArticleGoogle Scholar
- Oliveira AB, Dolabela MF, Braga FC, Jácome RLRP, Varotti FP, Póvoa MM. Plant-Derived Antimalarial Agents: New Leads and Efficient Phythomedicines. Part I. Alkaloids. An Acad Bras Cienc. 2009;81:715–40.View ArticlePubMedGoogle Scholar
- Krettli AU, Adebayo JO, Krettli LG. Testing of Natural Products and Synthetic Molecules Aiming at New Antimalarials. Curr Drug Targets. 2009;10:261–70.View ArticlePubMedGoogle Scholar
- Adugna M, Feyera T, Taddese W, Admasu P. In Vivo Antimalarial Activity of Crude Extract of Aerial Part of Artemisia abyssinica against Plasmodium berghei in Mice. Global J Pharmacol. 2014;8:460–8.Google Scholar
- Toma A, Deyno S, Fikru A, Eyado A, Beale A. In Vivo Antiplasmodial and Toxicological Effect of Crude Ethanol Extract of Echinops kebericho Traditionally Used in Treatment of Malaria in Ethiopia. Malar J. 2015;14:196.PubMed CentralView ArticlePubMedGoogle Scholar
- Builders MI, Uguru MO, Aguiyi C. Antiplasmodial Potential of the African Mistletoe: Agelanthus dodoneifolius Polh & Wiens. Indian J Pharm Sci. 2012;74:223–9.PubMed CentralView ArticlePubMedGoogle Scholar
- Akele B. In vivo Antimalarial Activity of Areal Part Extracts of Gardenia lutea and Sida rhombifolia. Int J Res Pharmacol and Pharmacotherapeutics. 2013;2:234–41.Google Scholar
- Adinew GM. Antimalarial Activity of Methanolic Extract of Phytolacca dodecandra Leaves against Plasmodium berghei Infected Swiss Albino Mice. Int J Pharmacol and Clin Sci. 2014;3:39–45.Google Scholar
- Deharo E, Bourdy G, Quenevo C, Munoz V, Ruiz G, Sauvain M. A Search for Natural Bioactive Compounds in Bolivia through a Multidisciplinary Approach. Part V. Evaluation of the Antimalarial Activity of Plants Used By the Tacana Indians. J Ethnopharmacol. 2001;77:91–8.View ArticlePubMedGoogle Scholar
- Al-Adhroey AH, Nor ZM, Al-Mekhlafi HM, Mahmud R. Median Lethal Dose, Antimalarial Activity, Phytochemical Screening and Radical Scavenging of Methanolic Languas galangal Rhizome Extract. Molecules. 2010;15:8366–76.View ArticlePubMedGoogle Scholar
- Ogbole EA, Ogbole PJY, Builders MI, Aguiyi JC. Phytochemical Screening and In Vivo Antiplasmodial Sensitivity Study of Locally Cultivated Artemisia annua Leaf Extract against Plasmodium berghei. Am J Ethnomed. 2014;1:042–9.Google Scholar
- Ajaiyeoba E, Falade M, Ogbole O, Okpako L, Akinboye D. In Vivo Antimalarial and Cytotoxic Properties of Annona senegalensis extract. Afr J Trad CAM. 2006;3:137–41.Google Scholar
- Petros Z, Melaku D. In Vivo Antiplasmodial Activity of Adhatoda schimperiana Leaf Extract in Mice. Pharmacologyonline. 2012;3:95–103.Google Scholar
- Saxena S, Pant N, Jain DC, Bhakuni RS. Antimalarial Agents from Plant Sources. Curr Sci. 2003;85:1314–29.Google Scholar
- Ginsburg H, Deharo E. A Call for Using Natural Compounds in the Development of New Antimalarial Treatments–An Introduction. Malar J. 2011;10:1–7.View ArticleGoogle Scholar
- Rasoanaivo P, Wright CW, Willcox ML, Gilbert B. Whole Plant Extracts versus Single Compounds for the Treatment of Malaria: Synergy and Positive Interactions. Malar J. 2011;10:4–15.View ArticleGoogle Scholar
- Mengiste B, Makonnen E, Urga K. In Vivo Antimalarial Activity of Dodonaea angustifolia Seed Extracts Against Plasmodium berghei in Mice Model. MEJS. 2012;4:47–63.Google Scholar
- Abdulelah HAA, Zainal-Abidin BAH. In Vivo Antimalarial Tests of Nigella sativa (Black Seed) Different Extracts. Am J Pharm & Toxicol. 2007;2:46–50.View ArticleGoogle Scholar
- Taherkhani M, Rustaiyan A, Nahrevanian H, Salehizadeh E. In Vivo Antimalarial Activity of Iranian Flora Artemisia oliveriana J. Gay ex DC. Extract and its Comparison with Other Antimalarial Drugs against Plasmodium berghei in Mice Model. TBAP. 2013;3:173–82.Google Scholar
- Salawu OA, Tijani AY, Babayi H, Nwaeze AC, Anagbogu RA, Agbakwuru VA. Antimalarial Activity of Ethanolic Stem Bark Extract of Faidherbia albida (Del) a. Chev (Mimosoidae) in Mice. Arch Appl Sci Res. 2010;2:261–8.Google Scholar